Treatment eligibility, medication selection, dosing, and program recommendations are determined by a licensed medical provider based on individual evaluation and applicable state regulations
Delta-tocotrienol supplementation improves biochemical markers of hepatocellular injury and steatosis in patients with nonalcoholic fatty liver disease: a randomized, placebo-controlled trial
In addition, increased risk of in-stent restenosis with such treatment has been reported in patients after coronary stenting (15)
Of course, NAFLD not only occurs in obese people, but also high-fat diet, lack of exercise, and gender are the causes of NAFLD too (Tokuhara, 2021)
Sharma S, Dominguez AL, Lustgarten J
Glucagon-like peptide 1 receptor induced suppression of food intake, and body weight is mediated by central IL-1 and IL-6